Skip to main content
Federal Circuit· 11/1/2010

ASTRAZENECA LP v. Apotex, Inc.

Citations

  • 633 F.3d 1042
  • 97 U.S.P.Q. 2d (BNA) 1029
  • 2010 U.S. App. LEXIS 22660
  • 2010 WL 4286284

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

  • explaining that the district court “correctly determined” that lan- guage in the ANDA label “would inevitably lead some consumers to practice the claimed method”
  • explaining that a court may rely on “uncontested expert testimony to explain how the invention described in the intrinsic record functions” in construing a term to avoid excluding an embodiment disclosed in the specification
  • holding circumstantial evidence may suffice to prove specific intent to induce infringement

Source: CourtListener parenthetical corpus (CC0).

Judges: Rader, Bryson, Linn

Read full opinion on CourtListener

Cited by

72 cases in this archive cite this case; the 20 most cited are listed.

Cites

35 cases in this archive are cited by this case; the 20 most cited are listed.

Other cases named ASTRAZENECA LP v. Apotex, Inc.

2 other CourtListener records share this case name.

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.